RU-486 plus prostaglandins remains the most effective nonsurgical abortion method

The most common medical approach to terminating early pregnancy — the drug RU-486 plus prostaglandins — remains the most effective nonsurgical abortion method, according to a new research review.

The analysis of six studies, led by Dr. Lale Say of the World Health Organization, notes that “failed abortion is an infrequent but important complication” of using medical techniques compared to surgical vacuum aspiration.

Efficacy rates in individual trials range from 76 percent to 97.2 percent for medical abortions compared with 94 percent to 100 percent for surgical methods. In addition, duration of bleeding seems to be longer with medical methods, and they may also be more painful.

Medical abortion methods used in the studies were RU-486 plus prostaglandins, RU-486 alone, prostaglandins alone and methotrexate plus prostaglandins. RU-486 alone had the lowest success rate of the medical methods, and the rate of failed abortions was also significantly higher in the prostaglandin-only group compared to surgery.

The review combines evidence from five randomized controlled trials in Sweden, Denmark, the United Kingdom and the United States, plus one conducted by the World Health Organization. The international trial included 12 centers in India, Vietnam, Slovenia, Zambia, China, Sweden, and Hungary.

The authors report that the trials have small sample sizes, and the results of the review are often based on one trial only. They call for additional trials to evaluate efficacy, side effects, and women’s preferences among medical and surgical first-trimester abortion methods.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose